Northpond Ventures
Cambridge, Massachusettsnorthpond.com
Overview
Northpond Ventures is a science-driven venture capital firm that invests in the biotechnology, diagnostics, digital health, and life science sectors. Founded in 2018, the firm partners with scientists, academics, and entrepreneurs to build and support breakthrough science and technology businesses. Northpond Ventures has offices in Cambridge, MA, Bethesda, MD, and San Francisco, CA.
Portfolio Companies
44
Website
northpond.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| VieCure | Jan 2026 | Series C | Lead |
| Elephas Biosciences | Nov 2025 | Series B Extension | Co-investor |
| Octave Bioscience | Sep 2025 | Series C | Co-investor |
| Garuda Therapeutics | Mar 2025 | Series A Extension | Co-investor |
| Ultivue | Oct 2024 | M&A | Co-investor |
Key People
Philip Slovitt
Managing Principal
Maddy Stein Kandelman
Portfolio Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
